Anti-CCR2/CD192 Antibody (Plozalizumab)
Catalog No.
F1115
Anti-CCR2/CD192 Antibody (Plozalizumab)
Featured Products
Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used in malignant melanoma research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.08 kDa
Dry ice
1610761-46-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TAK-202, MLN-1202
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P41597
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CCR2 / CD192
Please avoid freeze-thaw cycles.